drugset / Trial / NCT01307020

Analgesic Effect of Different Combinations of Dexketoprofen Trometamol With Tramadol Hydrochloride in a Model of Moderate to Severe Pain

NCT01307020

Phase 2 Completed 745 enrolled Menarini Group PRA Health Sciences · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the analgesic efficacy of Dexketoprofen Trometamol and Tramadol Hydrochloride given in combinations and the analgesic efficacy of each single component in comparison to placebo on moderate to severe pain following impacted third mandibular molar tooth extraction. Ibuprofen will be used as an active control to validate the pain model.

Timeline

Start
2011-02
Primary completion
2011-10
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexketoprofen Trometamol Small molecule 12.5 mg Oral
Subject Dexketoprofen Trometamol Small molecule 25 mg Oral
Comparator Ibuprofen Small molecule 400 mg Oral
Subject Tramadol Other / unclassified 37.5 mg Oral
Subject Tramadol Other / unclassified 75 mg Oral

Indications

No indication recorded.